BreastCarcinoma, Ductal, BreastBreast DiseasesBreast FeedingBreast Neoplasms, MaleReceptors, EstrogenMammographyFibrocystic Breast DiseaseCell Line, TumorBreast ImplantsReceptor, erbB-2Breast Self-ExaminationReceptors, ProgesteroneTamoxifenGene Expression Regulation, NeoplasticCarcinoma, Intraductal, NoninfiltratingMastectomyCarcinoma, LobularPrognosisTumor Markers, BiologicalNeoplasm InvasivenessUltrasonography, MammaryNeoplasm MetastasisGenes, BRCA1Antineoplastic Agents, HormonalLymphatic MetastasisRisk FactorsNeoplasm StagingCase-Control StudiesPostmenopauseImmunohistochemistryMastectomy, SegmentalMilk, HumanMammaplastyTumor Cells, CulturedBreast CystCarcinomaNeoplasm ProteinsChemotherapy, AdjuvantMCF-7 CellsMammary Glands, HumanFibroadenomaEstrogen Receptor alphaNipplesEstrogensAntineoplastic AgentsPremenopauseMammary Neoplasms, ExperimentalBreast ImplantationBRCA2 ProteinMenopauseBRCA1 ProteinAxillaGenes, BRCA2Cell ProliferationNeoplasms, Hormone-DependentTriple Negative Breast NeoplasmsInflammatory Breast NeoplasmsGenes, erbB-2Carcinoma, DuctalAromatase InhibitorsEstrogen AntagonistsCarcinoma in SituGenetic Predisposition to DiseaseNeoplasm Recurrence, LocalDisease-Free SurvivalGene Expression ProfilingSurvival AnalysisMice, NudeMass ScreeningTime FactorsDrug Resistance, NeoplasmFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeIncidenceCohort StudiesEstradiolRNA, MessengerRiskBiopsy, NeedleAge FactorsReverse Transcriptase Polymerase Chain ReactionProspective StudiesRetrospective StudiesSensitivity and SpecificityRisk AssessmentMastectomy, Modified RadicalSignal TransductionDNA, NeoplasmSurvival RateSelective Estrogen Receptor ModulatorsNeoadjuvant TherapyOdds RatioApoptosisCyclophosphamideOvarian NeoplasmsEpirubicinDisease ProgressionSurvivors